The use of medications in the secondary prevention of coronary artery disease in the Asian region
Dalal, Jamshed
Low, Lip-Ping
Dang, Van Phuoc
Low, Lip-Ping
Dang, Van Phuoc
Background:
Cardiovascular diseases, to which coronary artery disease (CAD) is a
significant contributor, are a leading cause of long-term morbidity and
mortality worldwide. In the years ahead, it is estimated that
approximately half of the world's cardiovascular burden will occur in
the Asian region. Currently there is a large gap in secondary
prevention, with unrealized health gains resulting from underuse of
evidence-based medications, including beta-blockers, angiotensin
converting enzyme (ACE) inhibitors, angiotensin receptor blockers
(ARBs), aspirin and other antiplatelet agents, and lipid-lowering drugs.
Despite the almost universal recommendation for these drugs in unstable
CAD, their under-prescription is well documented for patients with
acute heart failure, non-obstructive CAD, and for secondary prevention
of CAD.
Objective:
This article reviews the burden of CAD in Asian countries together with
guidelines supporting evidence-based medication use from a secondary
prevention perspective. Methods: The MEDLINE database was searched from
2000 to 2013, inclusive, for country-specific data related to CAD and
supplemented with unpublished registry data.
Results:
In the post-discharge setting following hospital admission for acute
coronary syndromes, medication prescription rates were low. Beta-blocker
prescription rates ranged from 49% in China to 99% in Singapore,
ACE-inhibitor/ARB prescription rates ranged from 28% in China to 96% in
Singapore, and lipid-lowering therapy rates ranged from 47% in China to
97% in Singapore. Aspirin/antiplatelet drug prescription rates ranged
from 86% in Indonesia to 99.5% in Singapore. Recommendations are
provided to improve patient outcomes and reduce the disease burden in
Asia.
Chi tiết xin mời tham khảo tại http://repository.vnu.edu.vn/handle/VNU_123/32352
| Title: | The use of medications in the secondary prevention of coronary artery disease in the Asian region |
| Authors: | Dalal, Jamshed Low, Lip-Ping Dang, Van Phuoc |
| Keywords: | Angiotensin converting enzyme inhibitors;Asian countries;Aspirin;Beta-blockers;Coronary artery disease |
| Issue Date: | 2015 |
| Publisher: | INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND |
| Citation: | ISIKNOWLEDGE |
| Description: | CURRENT MEDICAL RESEARCH AND OPINION Volume: 31 Issue: 3 Pages: 423-433 Published: MAR 2015 ; TNS05746 |
| URI: | http://www.tandfonline.com/doi/abs/10.1185/03007995.2015.1010035?src=recsys&journalCode=icmo20 http://repository.vnu.edu.vn/handle/VNU_123/32352 |
| ISSN: | 0300-7995 |
| Appears in Collections: | Bài báo của ĐHQGHN trong Web of Science |
Nhận xét
Đăng nhận xét